Towards a judicious use of perilesional biopsy in the era of MRI-targeting, parting of the ways from systematic prostate biopsy

Anwar R Padhani¹, Steven S Raman², Ivo G Schoots^{3

4}

Affiliations

¹ Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, Rickmansworth Road, Northwood, Middlesex, HA6 2RN, UK. anwar.padhani@stricklandscanner.org.uk.
² Department of Radiological Sciences, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
³ Department of Radiology and Nuclear Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
⁴ Department of Radiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.

Editorial

Anwar R Padhani et al. Eur Radiol. 2022 Nov.

. 2022 Nov;32(11):7491-7493.

doi: 10.1007/s00330-022-09097-4. Epub 2022 Sep 8.

Anwar R Padhani¹, Steven S Raman², Ivo G Schoots^{3

4}

¹ Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, Rickmansworth Road, Northwood, Middlesex, HA6 2RN, UK. anwar.padhani@stricklandscanner.org.uk.
² Department of Radiological Sciences, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
³ Department of Radiology and Nuclear Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
⁴ Department of Radiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.

No abstract available

Keywords: Diagnosis; Image-guided biopsy; Multiparametric magnetic resonance imaging; Prostatic neoplasms.

Comment on

Prostate biopsy in the era of MRI-targeting: towards a judicious use of additional systematic biopsy.
Deniffel D, Perlis N, Ghai S, Girgis S, Healy GM, Fleshner N, Hamilton R, Kulkarni G, Toi A, van der Kwast T, Zlotta A, Finelli A, Haider MA. Deniffel D, et al. Eur Radiol. 2022 Nov;32(11):7544-7554. doi: 10.1007/s00330-022-08822-3. Epub 2022 May 4. Eur Radiol. 2022. PMID: 35507051

1. Williams C, Ahdoot M, Daneshvar MA et al (2022) Why does magnetic resonance imaging-targeted biopsy miss clinically significant cancer? J Urol 207:95–107. https://doi.org/10.1097/JU.0000000000002182 - DOI
1. Stavrinides V, Syer T, Hu Y et al (2021) False positive multiparametric magnetic resonance imaging phenotypes in the biopsy-naïve prostate: are they distinct from significant cancer-associated lesions? Lessons from PROMIS. Eur Urol 79:20–29. https://doi.org/10.1016/j.eururo.2020.09.043
1. Vickers AJ (2021) Effects of magnetic resonance imaging targeting on overdiagnosis and overtreatment of prostate cancer. Eur Urol 80:567–572. https://doi.org/10.1016/j.eururo.2021.06.026 - DOI
1. Mottet N, Cornford P, Van Den Bergh RCN (2022) EAU - EANM - ESTRO - ESUR - ISUP - SIOG guidelines on prostate cancer. EAU Guidel Edn Present EAU Annu Congr Amsterdam 2022 ISBN 978-94-92671-16-5
1. Deniffel D, Perlis N, Ghai S et al (2022) Prostate biopsy in the era of MRI-targeting: towards a judicious use of additional systematic biopsy. Eur Radiol. https://doi.org/10.1007/s00330-022-08822-3